ELYM

Eliem Therapeutics, Inc. (ELYM) | Rumor.io

Eliem Therapeutics

ELYM

Attention (50-day avg)0%

Attention rank (50-day avg)—

Bullish sentiment (50-day avg)—

Price to earnings ratio0

Market capitalization0

Earnings per share0

Dividend yield (TTM)—

Revenue (annual)0

Net income (annual)0

Social

What share of all stock conversation is about ELYM?

	1 Day1D	1 Week1W	1 Month1M	1 Year1Y	50-Day MAclick to plot	200-Day MAclick to plot
Attention	0% 0	0% new	0% new	0% 0

Apr 11

Eliem Therapeutics, Inc. (ELYM) has been listed on Coinstore, a cryptocurrency exchange, which may spark interest in the lesser-known token.
ELYM's focus on AI, Metaverse, and Web3 gaming could position it as a dark horse in the altcoin space, according to some market observers.
The listing has been met with enthusiasm from some in the crypto community, with many welcoming ELYM to the Coinstore family and expressing excitement about its potential.

Generated by AI

Sentiment

Of the messages about ELYM that take a side, what share is each?

	1 Day1D	1 Week1W	1 Month1M	1 Year1Y	50-Day MAclick to plot	200-Day MAclick to plot
Bullish	—	—	—	100% +22.15
Bearish	—	—	—	0% -22.15

Bullish· Sep 25

$ELYM has been added to the S&P Global BMI Index, providing institutional exposure and potentially driving long-term growth.
Insider sales in the past month may lead to short-term turbulence, but the company's ETX-155 pipeline for depression and seizures remains a strong catalyst for the stock.
The stock's 148% year-to-date gain and strong investor confidence, as seen in the acquisition of shares by Ally Bridge Group, suggest that the company has significant potential for further growth.

Bearish· Apr 11

The asset's 52-week high is at risk of being broken, with a key level of $4 currently holding as support.
The stock is experiencing heavy selling pressure, with a 12.73% decline in the last 13 minutes, and may continue to drop to $3.5.
The asset's recent pump and rise to $4.30 may have been a false signal, with the stock now struggling to maintain its price above $4.20-$4.30.

Generated by AI

Topics

Of the messages about ELYM that carry a topic, what share is each?

	1 Day1D	1 Week1W	1 Month1M	1 Year1Y
Analysts	—	0%	0%	0%
Announcements	—	100%	100%	100%
Controversies	—	0%	0%	0%
Earnings	—	0%	0%	0%
Macro	—	0%	0%	0%
Technical Analysis	—	0%	0%	0%

Announcements· Sep 25

Eliem Therapeutics, Inc. ($ELYM) announces strategic pipeline restructuring, leading to a 50% increase in after-hours trading.
Ally Bridge Group NY LLC acquired 500,000 shares in Eliem Therapeutics, Inc., indicating strong investor confidence in the company.
Psyence Biomed entered into an agreement to acquire a stake in PsyLabs, a subsidiary of Eliem Therapeutics, Inc., in a deal valued at $0.55.

Technical Analysis· Apr 11

$ELYM is expected to see a pop above $4.30 if it holds the 4.15 area, with potential targets at $4.75 and $5.25.
The stock has formed a bull coil near the apex, with a narrowing bull coil setup, and a potential breakout above $4.30.
$ELYM has broken and held above $4.30, with a strong push expected into premarket highs, and a test of premarket highs if it breaks above $4.30.

Generated by AI

Community

Of the messages about ELYM, what share comes from each group?

	1 Day1D	1 Week1W	1 Month1M	1 Year1Y	50-Day MAclick to plot	200-Day MAclick to plot
Regulars	—	0%	0%	0.82%
Newcomers	—	100%	100%	99.18%

Also Discussed

Investors talking about ELYM also mention

#	Name	Attention
1	ELP - Companhia Paranaense de Energia - COPEL	——
2	Rent the Runway, Inc. Class A Common StockRENT	0%0
3	Abrdn Healthcare Opportunities FundTHQ	0.01%new
4	HUDSON PACIFIC PROPERTIES INCHPP	0%new
5	Quanterix CorporationQTRX	0%new
6	Allogene Therapeutics IncALLO	0%new
7	iShares MSCI South Africa ETFEZA	0%0
8	Mira Pharmaceuticals, Inc.MIRA	0%0
9	Rallybio Corp.RLYB	0%0
10	BranchOut Food Inc.BOF	0%0